Suppr超能文献

“她才是知情者”:对口服和注射用暴露前预防药物的定性探索,作为多米尼加共和国和坦桑尼亚女性性工作者社区赋权艾滋病毒预防方法的一部分。

"She is the one who knows": A qualitative exploration of oral and injectable PrEP as part of a community empowerment approach to HIV prevention among female sex workers in the Dominican Republic and Tanzania.

作者信息

Mantsios Andrea, Muraleetharan Ohvia, Donastorg Yeycy, Perez Martha, Gomez Hoisex, Shembilu Catherine, Beckham S Wilson, Karver Tahilin Sanchez, Davis Wendy, Likindikoki Samuel, Mbwambo Jessie, Barrington Clare, Kerrigan Deanna

机构信息

Public Health Innovation & Action, New York, New York, United States of America.

Yale School of Public Health, New Haven, Connecticut, United States of America.

出版信息

PLOS Glob Public Health. 2022;2(9). doi: 10.1371/journal.pgph.0000981. Epub 2022 Sep 15.

Abstract

Despite documented interest among female sex workers (FSW), uptake of oral pre-exposure prophylaxis (PrEP) for HIV prevention has been low. Recent trials and regulatory approval of long-acting injectable (LAI) PrEP offer new hope for the potential of this biomedical intervention. We examined FSW's PrEP-related interest and preferences regarding both oral and LAI PrEP situating these dynamics within their specific social and occupational realities. We conducted this work using qualitative methods across two distinct contexts by conducting 40 in-depth interviews with FSW in Tanzania and the Dominican Republic. Textual data was coded using iterative thematic content analysis. Analytic summaries were developed and reviewed to identify recurring themes. We systematically organized themes within each country and then compared across settings. Women in both settings expressed strong interest in PrEP seeing it as an important option to protect themselves in their work. Most participants preferred LAI PrEP due to expectations of reduced stigma and concerns about daily pill adherence and side effects. Occupational factors such as alcohol use, overnight dates with clients, and fear of violence from clients were identified as barriers to daily oral PrEP. LAI PrEP was seen as having the potential to reduce stress related to oral PrEP. Women who preferred pills discussed fear of needles, skepticism about the injections, and others relayed that taking a daily pill would not be challenging for them. There was a pre-dominant sentiment that women know best whether they are better suited for oral or LAI PrEP. Participants stressed the importance of FSW understanding both options to ensure informed decision-making around PrEP and described community-led peer education as key to delivering trusted information. Community empowerment approaches led by FSW which address structural and psychosocial constraints and promote safe work environments may facilitate equitable access and uptake of PrEP among FSW across settings.

摘要

尽管有记录表明女性性工作者(FSW)对预防艾滋病病毒的口服暴露前预防(PrEP)存在兴趣,但该预防措施的采用率一直很低。长效注射用(LAI)PrEP的近期试验和监管批准为这种生物医学干预措施的潜力带来了新希望。我们研究了FSW对口服和LAI PrEP的PrEP相关兴趣和偏好,并将这些动态置于她们特定的社会和职业现实背景中。我们通过对坦桑尼亚和多米尼加共和国的FSW进行40次深入访谈,在两个不同背景下采用定性方法开展了这项工作。文本数据使用迭代主题内容分析法进行编码。编写并审查了分析摘要以确定反复出现的主题。我们在每个国家系统地组织主题,然后进行跨背景比较。两个背景下的女性都对PrEP表现出浓厚兴趣,将其视为在工作中保护自己的重要选择。由于期望减少耻辱感以及担心每日服药依从性和副作用,大多数参与者更喜欢LAI PrEP。饮酒、与客户过夜约会以及担心来自客户的暴力等职业因素被确定为每日口服PrEP的障碍。LAI PrEP被认为有可能减轻与口服PrEP相关的压力。选择口服药的女性讨论了对针头的恐惧、对注射的怀疑,而其他人则表示每日服药对她们来说并不困难。有一种普遍的观点认为,女性最清楚自己是否更适合口服或LAI PrEP。参与者强调FSW了解这两种选择对于确保围绕PrEP做出明智决策的重要性,并将社区主导的同伴教育描述为提供可信信息的关键。由FSW主导的社区赋权方法,解决结构性和心理社会限制因素并促进安全的工作环境,可能有助于在不同背景下的FSW中公平获取和采用PrEP。

相似文献

5
美国跨性别和非二元性别的年轻成年人对长效注射暴露前预防的认知与偏好
Qual Health Res. 2025 Jan;35(1):74-87. doi: 10.1177/10497323241265943. Epub 2024 Aug 2.
6
7
美国顺性别男性和跨性别女性及男男性行为者对注射用暴露前预防的偏好。
Arch Sex Behav. 2018 Oct;47(7):2101-2107. doi: 10.1007/s10508-017-1049-7. Epub 2017 Sep 19.
8
了解印度女性性工作者中使用口服暴露前预防措施的问题。
BMC Infect Dis. 2021 Sep 8;21(1):930. doi: 10.1186/s12879-021-06612-8.
9
纽约市男男性行为者对长效注射用HIV暴露前预防制剂的高度兴趣:一项P18队列子研究。
PLoS One. 2014 Dec 11;9(12):e114700. doi: 10.1371/journal.pone.0114700. eCollection 2014.

引用本文的文献

1
对津巴布韦女性性工作者坚持暴露前预防(PrEP)的生活经历进行的定性分析。
PLoS One. 2025 Sep 4;20(9):e0313366. doi: 10.1371/journal.pone.0313366. eCollection 2025.
3
药物之外:了解赞比亚性工作女性口服及长效注射用暴露前预防药物的障碍与促进因素
PLOS Glob Public Health. 2025 Jun 4;5(6):e0004461. doi: 10.1371/journal.pgph.0004461. eCollection 2025.
5
英国“向我咨询暴露前预防(PrEP)”艾滋病毒暴露前预防意识项目的调查结果。
J Eval Clin Pract. 2025 Aug;31(5):e14163. doi: 10.1111/jep.14163. Epub 2024 Oct 23.
7
西班牙马德里主要在户外工作的 cisgender 女性性工作者使用 HIV 暴露前预防和避孕套的意愿决定因素。
Arch Sex Behav. 2024 Jul;53(7):2817-2831. doi: 10.1007/s10508-024-02834-4. Epub 2024 Jun 10.
9
乌干达古卢市女性性工作者中暴露前预防用药情况:一项基于社区的横断面研究
Ther Adv Infect Dis. 2023 Sep 8;10:20499361231199550. doi: 10.1177/20499361231199550. eCollection 2023 Jan-Dec.

本文引用的文献

2
“ARV 中的任何成分也存在于 PrEP 中”——南非女性性工作者口服暴露前预防使用的相关挑战。
Front Public Health. 2022 Jun 17;10:691729. doi: 10.3389/fpubh.2022.691729. eCollection 2022.
3
长效暴露前预防药物有望实现公平可及?
Lancet HIV. 2022 Jul;9(7):e449. doi: 10.1016/S2352-3018(22)00167-9.
4
用于HIV预防的长效卡博特韦:可及性、成本与公平性问题
JAMA. 2022 Mar 8;327(10):921-922. doi: 10.1001/jama.2022.0420.
5
乌干达从事性工作的女性对暴露前预防的接受度及启动情况:对艾滋病预防的启示
EClinicalMedicine. 2022 Jan 28;44:101278. doi: 10.1016/j.eclinm.2022.101278. eCollection 2022 Feb.
6
了解印度女性性工作者中使用口服暴露前预防措施的问题。
BMC Infect Dis. 2021 Sep 8;21(1):930. doi: 10.1186/s12879-021-06612-8.
7
卡博特韦用于预防顺性别男性和跨性别女性中的 HIV。
N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016.
8
了解津巴布韦女性性工作者对 PrEP 的早期接受情况。
AIDS Care. 2021 Jun;33(6):729-735. doi: 10.1080/09540121.2020.1832192. Epub 2020 Oct 12.
10
女性性工作者的暴露前预防依从性综述。
Yonsei Med J. 2020 May;61(5):349-358. doi: 10.3349/ymj.2020.61.5.349.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验